HALLIE WATERS: Open Payments
NPI 1669250452 · MIDLOTHIAN, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$746 in 36 payments from 11 companies in 2025. Trend: 2023 $33 · 2024 $1,209 · 2025 $746
Food & beverage: $746
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 11 | $210 |
| Lilly USA, LLC | 4 | $159 |
| Novo Nordisk Inc | 6 | $96 |
| PFIZER INC. | 5 | $95 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $48 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $33 |
| AstraZeneca Pharmaceuticals LP | 2 | $31 |
| Axsome Therapeutics, Inc. | 1 | $24 |
| Esperion Therapeutics, Inc. | 1 | $18 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $16 |
Products named: UBRELVY, ZEPBOUND, QULIPTA, NURTEC ODT, JARDIANCE, CAPLYTA, ELIQUIS, MOUNJARO.
Industry payments across VA — which companies pay providers there.
